» Articles » PMID: 32825681

Blockade of Hemichannels Normalizes the Differentiation Fate of Myoblasts and Features of Skeletal Muscles from Dysferlin-Deficient Mice

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Aug 23
PMID 32825681
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Dysferlinopathies are muscle dystrophies caused by mutations in the gene encoding dysferlin, a relevant protein for membrane repair and trafficking. These diseases are untreatable, possibly due to the poor knowledge of relevant molecular targets. Previously, we have shown that human myofibers from patient biopsies as well as myotubes derived from immortalized human myoblasts carrying a mutated form of dysferlin express connexin proteins, but their relevance in myoblasts fate and function remained unknown. In the present work, we found that numerous myoblasts bearing a mutated dysferlin when induced to acquire myogenic commitment express PPARγ, revealing adipogenic instead of myogenic commitment. These cell cultures presented many mononucleated cells with fat accumulation and within 48 h of differentiation formed fewer multinucleated cells. In contrast, dysferlin deficient myoblasts treated with boldine, a connexin hemichannels blocker, neither expressed PPARγ, nor accumulated fat and formed similar amount of multinucleated cells as wild type precursor cells. We recently demonstrated that myofibers of skeletal muscles from blAJ mice (an animal model of dysferlinopathies) express three connexins (Cx39, Cx43, and Cx45) that form functional hemichannels (HCs) in the sarcolemma. In symptomatic blAJ mice, we now show that eight-week treatment with a daily dose of boldine showed a progressive recovery of motor activity reaching normality. At the end of this treatment, skeletal muscles were comparable to those of wild type mice and presented normal CK activity in serum. Myofibers of boldine-treated blAJ mice also showed strong dysferlin-like immunoreactivity. These findings reveal that muscle dysfunction results from a pathophysiologic mechanism triggered by mutated dysferlin and downstream connexin hemichannels expressed de novo lead to a drastic reduction of myogenesis and favor muscle damage. Thus, boldine could represent a therapeutic opportunity to treat dysfernilopathies.

Citing Articles

The Unexplored Role of Connexin Hemichannels in Promoting Facioscapulohumeral Muscular Dystrophy Progression.

Diaz-Ubilla M, Retamal M Int J Mol Sci. 2025; 26(1.

PMID: 39796228 PMC: 11719937. DOI: 10.3390/ijms26010373.


Muscle-restricted knockout of connexin 43 and connexin 45 accelerates and improves locomotor recovery after contusion spinal cord injury.

Toro C, De Gasperi R, Vanselow K, Harlow L, Johnson K, Aslan A Front Physiol. 2024; 15:1486691.

PMID: 39524606 PMC: 11543431. DOI: 10.3389/fphys.2024.1486691.


Pharmacology of boldine: summary of the field and update on recent advances.

Saez J, Burrell J, Cahill C, Cullen D, Devi L, Gilbert R Front Pharmacol. 2024; 15:1427147.

PMID: 39346563 PMC: 11427365. DOI: 10.3389/fphar.2024.1427147.


Cardiac Fibroblasts Enhance MMP2 Activity to Suppress Gap Junction Function in Cardiomyocytes.

Bai X, Huang X, Yi J, Yan X, Hu T, Wang L Appl Biochem Biotechnol. 2024; 196(12):8493-8512.

PMID: 38878160 DOI: 10.1007/s12010-024-04986-4.


The Dysferlinopathies Conundrum: Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments.

Anwar S, Yokota T Biomolecules. 2024; 14(3).

PMID: 38540676 PMC: 10968265. DOI: 10.3390/biom14030256.


References
1.
Retamal M, Schalper K, Shoji K, Bennett M, Saez J . Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential. Proc Natl Acad Sci U S A. 2007; 104(20):8322-7. PMC: 1895948. DOI: 10.1073/pnas.0702456104. View

2.
Leung C, Utokaparch S, Sharma A, Yu C, Abraham T, Borchers C . Proteomic identification of dysferlin-interacting protein complexes in human vascular endothelium. Biochem Biophys Res Commun. 2011; 415(2):263-9. DOI: 10.1016/j.bbrc.2011.10.031. View

3.
Gu W, Schneider J, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B . Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell. 1993; 72(3):309-24. DOI: 10.1016/0092-8674(93)90110-c. View

4.
Aguiari P, Leo S, Zavan B, Vindigni V, Rimessi A, Bianchi K . High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci U S A. 2008; 105(4):1226-31. PMC: 2234120. DOI: 10.1073/pnas.0711402105. View

5.
Agarwal A, Tunison K, Mitsche M, McDonald J, Garg A . Insights into lipid accumulation in skeletal muscle in dysferlin-deficient mice. J Lipid Res. 2019; 60(12):2057-2073. PMC: 6889719. DOI: 10.1194/jlr.RA119000399. View